Progress was reversed due to an increase in mortality from external causes and stagnation for cardiovascular diseases.
Upward trends in breast cancer incidence continuing among women
By
HealthDay News
Oct 01, 2024
Although mortality rates are down overall, progress has not been experienced by all women, with racial disparities still seen.
Cancer incidence rates in 2021 indicate return to prepandemic levels
By
HealthDay News
Sep 30, 2024
A recovery incorporating the delayed diagnoses from 2020 was not seen for overall cancer incidence.
Incidence of cardiovascular disease higher for seniors with cancer
By
HealthDay News
Sep 23, 2024
The greatest incidence was seen for metastatic, hematological and lung cancer; an increased risk for CVD was seen with chemotherapy.
Study looks at sex differences in melanoma incidence
By
HealthDay News
Sep 17, 2024
Melanoma incidence is highest on the trunk in men; incidence is historically highest on limbs in women, but recent increases were seen in truncal melanoma.
COVID-19 continues to affect leading causes of death in US: CDC
By
Kimberly Bonvissuto
Aug 12, 2024
The COVID-19 pandemic radically altered the rankings of the leading causes of death in the United States in 2020, and although COVID ranks lower on the list of causes in 2023, its effects continue to be...
Endocrine Society, June 1-4
Jun 20, 2024
The conference highlighted recent advances in the diagnosis and management of obesity, endocrine disorders, diabetes, and growth hormone and thyroid diseases.
Tiny throat patch turns muscle movement into speech for seniors with speaking disorders
By
Aaron Dorman
Mar 15, 2024
A new throat patch tool combines AI with electrical stimulation to assist those with voice disorders to regain their speech.
Observed rates of cancer diagnoses lower than expected in pandemic
Feb 26, 2024
The rate of all-sites cancer incidence was 28.6% lower than expected during the height of the COVID-19 pandemic response.
Digital rectal exam has low diagnostic value for prostate cancer
Jan 26, 2024
Low diagnostic value was seen as an independent test and supplementary measure to PSA for detection of prostate cancer.